2013: Dream Teams

PCF creates multidisciplinary Dream Teams of precision oncology researchers.

Xofigo – a unique alpha particle that’s been shown to be effective in treating metastatic disease – becomes the sixth new drug treatment in three years to receive FDA approval.

The International Dream Team, led by Arul Chinnaiyan, MD, PhD (University of Michigan), and Charles Sawyers, MD (Memorial Sloan Kettering Cancer Center), gets to work assembling a data bank of prostate cancer genomics that – when it is completed in 2015 – surpasses anything previously created for cancer research.

The West Coast Dream Team (pictured), led by Eric Small, MD (University of California, San Francisco), and Owen Witte, MD (University of California, Los Angeles), starts conducting a large-scale molecular study of treatment-resistant tumors to assess how they use common cellular responses, known as adaptive pathways, to circumvent even the newest therapies for this disease.